| Literature DB >> 25383623 |
Robert W Li1, Juan Gabriel Giarrizzo2, Sitao Wu3, Weizhong Li3, Jennifer M Duringer4, A Morrie Craig2.
Abstract
The manufacturing processes of royal demolition explosive (RDX), or hexahydro-1,3,5-trinitro-1,3,5-triazine, have resulted in serious water contamination. As a potential carcinogen, RDX can cause a broad range of harmful effects to humans and animals. The ovine rumen is capable of rapid degradation of nitroaromatic compounds, including RDX. While ruminal RDX-degrading bacteria have been identified, the genes and pathways responsible for RDX degradation in the rumen have yet to be characterized. In this study, we characterized the metabolic potential of the ovine rumen using metagenomic approaches. Sequences homologous to at least five RDX-degrading genes cloned from environmental samples (diaA, xenA, xenB, xplA, and xplB) were present in the ovine rumen microbiome. Among them, diaA was the most abundant, likely reflective of the predominance of the genus Clostridium in the ovine rumen. At least ten genera known to harbor RDX-degrading microorganisms were detectable. Metagenomic sequences were also annotated using public databases, such as Pfam, COG, and KEGG. Five of the six Pfam protein families known to be responsible for RDX degradation in environmental samples were identified in the ovine rumen. However, increased substrate availability did not appear to enhance the proliferation of RDX-degrading bacteria and alter the microbial composition of the ovine rumen. This implies that the RDX-degrading capacity of the ovine rumen microbiome is likely regulated at the transcription level. Our results provide metagenomic insights into the RDX-degrading potential of the ovine rumen, and they will facilitate the development of novel and economic bioremediation strategies.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25383623 PMCID: PMC4226467 DOI: 10.1371/journal.pone.0110505
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1RDX degradation by the ovine rumen microbiome over time.
Error bars represent SE (N = 5).
The relative abundance of genes involved in RDX degradation in the ovine rumen.
| Gene | Treatment | Incubation (minutes) | |||
| 10 | 60 | 150 | 240 | ||
|
| |||||
| −RDX | 49.76±25.87 | 56.50±20.91 | 55.70±23.10 | 54.70±13.70 | |
| +RDX | 44.49±7.52 | 41.86±9.25 | 52.70±15.14 | 38.68±14.83 | |
|
| |||||
| −RDX | 7.58±3.92 | 8.04±5.65 | 8.87±6.96 | 6.57±4.16 | |
| +RDX | 4.48±2.32 | 6.25±3.66 | 7.59±4.25 | 5.52±5.52 | |
|
| |||||
| −RDX | 5.22±3.57 | 4.47±1.26 | 4.74±1.66 | 5.34±3.63 | |
| +RDX | 4.72±1.52 | 4.64±1.06 | 3.91±1.88 | 3.90±1.97 | |
*The number denotes BLASTP hits per 10 million input sequences (±SD). The minimum % identity cutoff was 70%; the minimum alignment length was 21 amino acids.
Figure 2The 20 most common Pfam protein families in the ovine rumen microbiome.
Error bars represent SD (N = 5). X-axis: relative abundance (%).
The relative abundance of Pfam protein families and Gene Ontology (GO) involved in RDX degradation remained unchanged in the ovine rumen microbiome during RDX incubation.
| Pfam | Treatment | Incubation (minutes)* | |||
| 10 | 60 | 150 | 240 | ||
| PF00067 (p450) | |||||
| −RDX | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | |
| +RDX | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 | 3.39±4.66 | |
| PF00258 (Flavodoxin_1) | |||||
| −RDX | 2.93±0.18 | 2.89±0.95 | 3.71±1.59 | 2.37±1.50 | |
| +RDX | 3.41±2.33 | 2.69±1.74 | 2.96±0.28 | 3.22±0.89 | |
| PF00301 (Rubredoxin) | |||||
| −RDX | 3.91±0.91 | 3.90±0.81 | 3.77±0.79 | 4.61±3.36 | |
| +RDX | 4.83±1.05 | 2.31±1.65 | 3.71±0.61 | 3.42±1.88 | |
| PF00724 (Oxidored_FMN) | |||||
| −RDX | 2.33±0.91 | 2.17±1.39 | 2.21±1.61 | 6.00±6.03 | |
| +RDX | 2.68±1.91 | 4.15±2.31 | 3.08±1.81 | 1.63±0.89 | |
| PF01613 (Flavin_Reduct) | |||||
| −RDX | 5.39±0.98 | 5.02±0.62 | 5.83±0.80 | 5.89±2.65 | |
| +RDX | 5.59±2.07 | 4.83±1.91 | 4.81±1.95 | 3.23±0.88 | |
| GO:0016491 (Oxidoreductase activity) | |||||
| −RDX | 2.30±0.03 | 2.31±0.05 | 2.52±0.08 | 2.32±0.09 | |
| +RDX | 2.37±0.07 | 2.08±0.21 | 2.46±0.04 | 2.29±0.16 | |
| GO:0055114 (Oxidation-reduction process) | |||||
| −RDX | 1.88±0.04 | 1.91±0.05 | 1.96±0.07 | 1.83±0.06 | |
| +RDX | 1.86±0.06 | 1.70±0.18 | 2.07±0.06 | 1.96±0.12 | |
Note: *the number (mean±SE) denotes normalized counts of ORFs positively assigned to this Pfam (per 10,000 ORFs assigned to any Pfam families or percentage of hits assigned to the GO term.
Figure 3Functional categories affected by RDX exposure to the ovine rumen microbiome, annotated using the COG database.
Blue: control (N = 5); Red: RDX exposure (N = 5).
The relative abundance of 40 KEGG Orthology (KO) pathways with (+) and without (–) RDX incubation in the ovine rumen.
| 150 min | 240 min | ||||
| KO_id | Pathway | –RDX | +RDX | –RDX | +RDX |
| ko00970 | Aminoacyl-tRNAbiosynthesis | 6.87±1.19 | 7.18±0.71 | 6.78±0.82 | 6.07±1.50 |
| ko03010 | Ribosome | 6.68±1.46 | 6.44±1.69 | 7.65±2.73 | 5.31±1.76 |
| ko00250 | Alanine, aspartate andglutamate metabolism | 4.68±0.53 | 4.87±0.58 | 4.38±0.81 | 3.88±1.30 |
| ko00230 | Purine metabolism | 3.74±0.45 | 3.74±0.19 | 3.56±0.28 | 3.09±0.72 |
| ko00260 | Glycine, serine and threoninemetabolism | 3.56±0.27 | 3.49±0.35 | 3.34±0.48 | 2.96±0.93 |
| ko02010 | ABC transporters | 3.51±0.40 | 3.65±1.13 | 4.30±1.92 | 3.53±2.43 |
| ko00190 | Oxidative phosphorylation | 2.66±0.11 | 2.66±0.21 | 2.74±0.54 | 2.18±0.69 |
| ko03020 | RNA polymerase | 2.46±0.32 | 2.58±0.19 | 2.57±0.61 | 2.35±0.62 |
| ko03030 | DNA replication | 2.43±0.08 | 2.50±0.25 | 2.80±0.45 | 2.15±0.59 |
| ko03018 | RNA degradation | 2.35±0.42 | 2.55±0.26 | 2.75±0.43 | 2.47±0.28 |
| ko03070 | Bacterial secretion system | 2.20±0.35 | 2.30±0.14 | 2.36±0.41 | 1.87±0.73 |
| ko00240 | Pyrimidine metabolism | 2.06±0.37 | 1.95±0.07 | 1.88±0.25 | 1.61±0.49 |
| ko00010 | Glycolysis/Gluconeogenesis | 2.06±0.20 | 2.19±0.35 | 1.94±0.38 | 1.99±0.72 |
| ko00270 | Cysteine and methioninemetabolism | 1.95±0.27 | 1.97±0.28 | 1.80±0.20 | 1.59±0.45 |
| ko00040 | Pentose and glucuronateinterconversions | 1.90±0.43 | 1.65±0.55 | 1.48±0.80 | 1.35±0.54 |
| ko00330 | Arginine and proline metabolism | 1.89±0.19 | 1.77±0.16 | 1.66±0.39 | 1.64±0.56 |
| ko04112 | Cell cycle - Caulobacter | 1.86±0.21 | 1.85±0.07 | 1.97±0.37 | 1.37±0.37 |
| ko02020 | Two-component system | 1.84±0.05 | 1.71±0.28 | 1.68±0.30 | 1.49±0.45 |
| ko03440 | Homologous recombination | 1.81±0.27 | 1.62±0.27 | 1.94±0.56 | 1.42±0.54 |
| ko00051 | Fructose and mannose metabolism | 1.80±0.13 | 1.79±0.04 | 1.53±0.35 | 1.32±0.29 |
| ko00052 | Galactose metabolism | 1.69±0.10 | 1.63±0.36 | 1.51±0.35 | 1.28±0.48 |
| ko00520 | Amino sugar and nucleotide sugar metabolism | 1.67±0.25 | 1.54±0.37 | 1.42±0.30 | 1.34±0.51 |
| ko00550 | Peptidoglycan biosynthesis | 1.63±0.15 | 1.68±0.20 | 1.73±0.26 | 1.24±0.40 |
| ko00500 | Starch and sucrose metabolism | 1.61±0.17 | 1.45±0.13 | 1.41±0.16 | 1.28±0.35 |
| ko03420 | Nucleotide excision repair | 1.59±0.47 | 1.68±0.36 | 1.65±0.22 | 1.28±0.34 |
| ko00300 | Lysine biosynthesis | 1.49±0.12 | 1.38±0.08 | 1.31±0.27 | 1.16±0.41 |
| ko00020 | Citrate cycle (TCA cycle) | 1.46±0.08 | 1.50±0.38 | 1.41±0.33 | 1.18±0.47 |
| ko00620 | Pyruvate metabolism | 1.40±0.27 | 1.47±0.25 | 1.26±0.14 | 1.24±0.53 |
| ko00340 | Histidine metabolism | 1.34±0.16 | 1.21±0.17 | 1.20±0.24 | 0.98±0.35 |
| ko00400 | Phe, tyr and try biosynthesis | 1.19±0.35 | 1.19±0.32 | 0.97±0.47 | 0.75±0.36 |
| ko00030 | Pentose phosphate pathway | 1.18±0.16 | 1.24±0.06 | 1.11±0.14 | 0.94±0.24 |
| ko00280 | Valine, leucine and isoleucinedegradation | 1.14±0.34 | 1.22±0.16 | 1.32±0.25 | 1.11±0.34 |
| ko00061 | Fatty acid biosynthesis | 1.13±0.14 | 1.24±0.11 | 1.10±0.33 | 0.99±0.26 |
| ko00540 | Lipopolysaccharide biosynthesis | 1.10±0.13 | 1.10±0.12 | 1.21±0.28 | 0.80±0.24 |
| ko00290 | Valine, leucine and isoleucinebiosynthesis | 1.08±0.23 | 1.15±0.30 | 0.88±0.50 | 0.86±0.33 |
| ko00900 | Terpenoid backbone biosynthesis | 1.07±0.07 | 1.06±0.11 | 1.17±0.11 | 0.88±0.28 |
| ko00860 | Porphyrin and chlorophyllmetabolism | 1.05±0.36 | 1.04±0.38 | 0.78±0.39 | 0.86±0.17 |
| ko00940 | Phenylpropanoid biosynthesis | 1.03±0.30 | 0.99±0.47 | 0.76±0.66 | 0.73±0.52 |
| ko00521 | Streptomycin biosynthesis | 0.99±0.14 | 1.02±0.12 | 1.13±0.23 | 0.83±0.31 |
| ko00760 | Nicotinate and nicotinamidemetabolism | 0.89±0.16 | 0.96±0.04 | 1.03±0.26 | 0.85±0.29 |
Figure 4Relative abundance of sequences annotated to the KEGG Xenobiotic Biodegradation and Metabolism term during exposure of the ovine rumen to RDX over four hours.
Boxes denote the inter-quartile range between the first and third quartiles (25 and 75%, respectively). (–): time-matched WRF control without RDX exposure. (+): WRF incubated with 40 µg/µl RDX.